IP Library Granted Patent US 12,196,764
Granted Patent B2
US 12,196,764 · App. 17/523,113 · Granted Jan 14, 2025

Analysis techniques for measuring glycated hemoglobin in undiluted blood samples

Inventor: Jim Connolly (Indianapolis, IN)
G01N33/726A61B5/14532A61B5/14535A61B5/150358G01N33/723
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,196,764
App. No.
17/523,113
Granted
Jan 14, 2025
Kind
B2
Abstract

Electrochemical test sensors and analysis methods are described that reduce or eliminate the pre-treatment or dilution of blood samples prior to HbA1c analysis. Thus, a blood sample obtained from a blood draw or phlebotomy may be introduced to the electrochemical test sensor for HbA1c analysis. The described test sensors immobilize or deactivate incompatible reagents, enzymes, and antibodies so they do not substantially interfere with each other during the analysis. The test sensors also use heat to catalyze reactions that otherwise would proceed at too slow of a rate to be practical.

Claims (37)

1. A method of determining a corrected glycated hemoglobin concentration of an undiluted whole blood sample, the method comprising:

introducing an undiluted whole blood sample to a test sensor;

applying a potential to at least two electrical conductors of a hematocrit flow path;

determining an output current responsive to a hematocrit content of the sample;

applying a potential to a total hemoglobin working and counter electrode pair;

determining an output current from the total hemoglobin working and counter electrode pair responsive to a total hemoglobin concentration of the sample;

applying a potential to a glycated hemoglobin working and counter electrode pair;

determining an output current from the glycated hemoglobin working and counter electrode pair responsive to a glycated hemoglobin concentration of the sample; and

determining a corrected glycated hemoglobin concentration of the sample from the output currents, the output currents determined from

the hematocrit flow path,

the total hemoglobin working and counter electrode pair, and

the glycated hemoglobin working and counter electrode pair.

2. The method of claim 1 , where the applying the potential to at least two electrical conductors of the hematocrit flow path includes applying the potential to at least four electrical conductors of the hematocrit flow path and the determining the output current responsive to the hematocrit content of the sample includes determining at least three timing values from the at least four electrical conductors, the at least three timing values responsive to an entry rate of the sample through the test sensor.

3. The method of claim 2 , further comprising determining a value responsive to sample viscosity from the at least three timing values.

4. The method of claim 1 where the applying the potential to at least two conductors of the hematocrit flow path includes applying the potential to a hematocrit working and counter electrode pair and the determining the output current responsive to the hematocrit content of the sample includes determining an output current from the hematocrit working and counter electrode pair.

5. The method of claim 4 , where the output current determined from the hematocrit working and counter electrode pair is responsive to the electrical conductivity of the sample.

6. The method of claim 1 , further comprising before applying the potential to the total hemoglobin working and counter electrode pair, contacting the sample with a first chemical reaction zone and a pH adjustment zone.

7. The method of claim 6 , where the contacting the sample with the first chemical reaction zone lyses red blood cells in the sample and reduces lysate interference in the corrected glycated hemoglobin concentration determined from the sample.

8. The method of claim 6 , where the contacting the sample with the pH adjustment zone alters the pH of the sample.

9. The method of claim 1 , further comprising before applying the potential to the glycated hemoglobin working and counter electrode pair, contacting the sample with a first chemical reaction zone, a second chemical reaction zone, a pH adjustment zone, and an enzyme.

10. The method of claim 9 , where the contacting the sample with the second chemical reaction zone reduces the length of at least one peptide chain in the sample.

11. The method of claim 1 , where the contacting the sample with the enzyme produces an electrochemically active species having a concentration in the sample responsive to a glycated hemoglobin concentration of the sample.

12. The method of claim 1 , further comprising heating the total hemoglobin working and counter electrode pair and the glycated hemoglobin working and counter electrode pair to a temperature from 35 to 54 degrees Celsius before applying the potential to the total hemoglobin working and counter electrode pair and the glycated hemoglobin working and counter electrode pair, respectively.

13. The method of claim 1 , further comprising

applying a potential to an electrochemical background working and counter electrode pair;

determining an output current from the electrochemical background working and counter electrode pair responsive to an electrochemical background of the sample, where the determining the corrected glycated hemoglobin concentration of the sample from the output currents includes at least one current determined from the electrochemical background working and counter electrode pair.

14. The method of claim 13 , further comprising before applying the potential to the electrochemical background working and counter electrode pair, contacting the sample with a first chemical reaction zone, a second chemical reaction zone, and a pH adjustment zone.

15. The method of claim 13 , where the electrochemical background working and counter electrode pair lack an enzyme capable of producing an electrochemically active species.

16. The method of claim 13 , further comprising heating the electrochemical background working and counter electrode pair to a temperature from 35 to 54 degrees Celsius before applying the potential to the electrochemical background working and counter electrode pair.

17. The method of claim 1 , further comprising

applying a potential to an endogenous glycated hemoglobin background working and counter electrode pair;

determining an output current from the endogenous glycated hemoglobin background working and counter electrode pair responsive to an endogenous glycated hemoglobin background of the sample, where the determining the corrected glycated hemoglobin concentration of the sample from the output currents includes at least one current determined from the endogenous glycated hemoglobin background working and counter electrode pair.

18. The method of claim 17 , further comprising before applying the potential to the endogenous glycated hemoglobin background working and counter electrode pair, contacting the sample with a first chemical reaction zone, a pH adjustment zone, and an enzyme.

19. The method of claim 17 , further comprising heating the endogenous glycated hemoglobin working and counter electrode pair to a temperature from 35 to 54 degrees Celsius before applying the potential to the endogenous glycated hemoglobin background working and counter electrode pair.

20. The method of claim 18 , where the contacting the sample with the enzyme produces an electrochemically active species having a concentration in the sample responsive to a glycated hemoglobin concentration of the sample.

21. The method of claim 1 , where the determining the corrected glycated hemoglobin concentration of the sample includes determining a percent glycated hemoglobin to total hemoglobin value from the output currents determined from the glycated hemoglobin working and counter electrode pair and the total hemoglobin working and counter electrode pair, respectively.

22. The method of claim 21 , where the determining the corrected glycated hemoglobin concentration of the sample includes correcting the percent glycated hemoglobin to total hemoglobin value with the output currents determined from the hematocrit flow path.

Continuity (2)
Division 15820611 · Nov 22, 2017
Related Publication 20220065876A1 · Mar 3, 2022
References Cited (59)
US 4876205A · Green et al. · 1989 [cited by applicant]
US 6127138A · Ishimaru et al. · 2000 [cited by applicant]
US 6392209B1 · Oppitz · 2002 [cited by applicant]
US 6475360B1 · Hodges et al. · 2002 [cited by applicant]
US 6632349B1 · Hodges et al. · 2003 [cited by applicant]
US 7306283B2 · Howick et al. · 2007 [cited by applicant]
US 7330283B2 · Lee et al. · 2008 [cited by applicant]
US 7491310B2 · Okuda et al. · 2009 [cited by applicant]
US 7749764B2 · Su et al. · 2010 [cited by applicant]
US 8460524B2 · Popovich et al. · 2013 [cited by applicant]
US 8603309B2 · Cai et al. · 2013 [cited by applicant]
US 8673646B2 · Yuan et al. · 2014 [cited by applicant]
US 8815076B2 · Cardosi et al. · 2014 [cited by applicant]
US 20040063213A1 · Hirai et al. · 2004 [cited by applicant]
US 20050019488A1 · McCabe et al. · 2005 [cited by applicant]
US 20050195488A1 · McCabe et al. · 2005 [cited by applicant]
US 20070000780A1 · Oya et al. · 2007 [cited by applicant]
US 20070242111A1 · Pamula et al. · 2007 [cited by applicant]
US 20090000947A1 · Akahori et al. · 2009 [cited by applicant]
US 20090009062A1 · Chuang et al. · 2009 [cited by applicant]
US 20090090623A1 · Chuang et al. · 2009 [cited by applicant]
US 20100025264A1 · Yuan et al. · 2010 [cited by applicant]
US 20110102127A1 · Schultes et al. · 2011 [cited by applicant]
US 20110172750A1 · Cassidy et al. · 2011 [cited by applicant]
US 20120261257A1 · Vanjari et al. · 2012 [cited by applicant]
US 20130010826A1 · Le Neel et al. · 2013 [cited by applicant]
US 20130193384A1 · Dorfman · 2013 [cited by applicant]
US 20140051159A1 · Bergstedt et al. · 2014 [cited by applicant]
US 20150226689A1 · Semancik et al. · 2015 [cited by applicant]
US 20160131537A1 · Aliane et al. · 2016 [cited by applicant]
US 20160279639A1 · Kim et al. · 2016 [cited by applicant]
US 20180163184A1 · Huang et al. · 2018 [cited by applicant]
US 20190154619A1 · Connolly · 2019 [cited by applicant]
US 20190317039A1 · Connolly · 2019 [cited by applicant]
US 20210310980A1 · Connolly · 2021 [cited by applicant]
EP 0313390A2 · 1989 [cited by applicant]
EP 1693461A1 · 2006 [cited by applicant]
EP 1914315A1 · 2008 [cited by applicant]
EP 1693461B1 · 2011 [cited by applicant]
EP 2568281A1 · 2013 [cited by applicant]
JP 03166701A · 1991 [cited by applicant]
JP 2006061019A · 2006 [cited by applicant]
JP 2009171874A · 2009 [cited by applicant]
KR 500009257 · 1995 [cited by applicant]
WO 9940411A1 · 1999 [cited by applicant]
WO 2013153406A1 · 2013 [cited by applicant]
WO 2016038526A1 · 2016 [cited by applicant]
WO 2017038956A1 · 2017 [cited by applicant]
European Patent Office “Communication pursuant to Article 94(3) EPC”, European Patent Office, Application No. 18 815 865.3, Jun. 22, 2023, 4 pages. [cited by applicant]
European Patent Office , “Communication pursuant to Article 94(3) EPC”, European Patent Office, Application No. 18 815 882.8, Jul. 3, 2023, 6 pages. [cited by applicant]
“International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2018/061722, mailed on Mar. 22, 2019”, 6 Pages. [cited by applicant]
“International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2018/061995, mailed on Mar. 11, 2019”, 19 Pages. [cited by applicant]
“International Search Report and Written Opinion received for PCT Patent Application No. PCTUS2018060979, mailed on Feb. 12, 2019”, 17 pages. [cited by applicant]
“Neutral Proteinase from [cited by applicant]
Ar-Rawi, A. H., et al., “Novel idea to monitor and measure blood hemoglobin noninvasively”, African Journal of Biotechnology vol. 9 (54), pp. 9295-9306, Dec. 27, 2010. Available online at http://www.academicjournals.org… [cited by applicant]
Baldwin, Richard P., et al., “Catalytic Reduction of Myoglobin and Hemoglobin at Chemically Modified Electrodes Containing Methylene Blue”, Analytical Chemistry, vol. 60, No. 20, Oct. 15, 1988, Oct. 15, 1988, 2263-2268. [cited by applicant]
Chawla , et al., “An Amperometric Hemoglobin A1c Biosensor Based on Immobilization of Fructosyl Amino Acid Oxidase onto Zinc Oxide Nanoparticles—Polypyrrole Film”, Analytical biochemistry, 430(2), 2012, 156-162. [cited by applicant]
Taylor, John Fuller, et al., “System Methemoglobin-Hemoglobin Potentials of The”, J. Biol. Chem. 1939, 131:649-662., Oct. 4, 1939, 649-662. [cited by applicant]
Treo, Ernesto F., et al., “Comparative Analysis of Hematocrit Measurements by Dielectric and Impedance Techniques”, IEEE Transactions on Biomedical Engineering, vol. 52, No. 3, Mar. 2005., Mar. 31, 2005, 549-552. [cited by applicant]